title: Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels.
abstract: Cholecystokinin (CCK) is one of the most abundant neuropeptides in the brain, where it interacts with two G protein-coupled receptors (CCK-1 and CCK-2). Activation of both CCK receptors increases the activity of PLC, resulting in increases in intracellular calcium ion (Ca(2+)) release and activation of PKC. Whereas high density of CCK receptors has been detected in the superficial layers of the entorhinal cortex (EC), the functions of CCK in this brain region have not been determined. Here, we studied the effects of CCK on neuronal excitability of layer III pyramidal neurons in the EC. Our results showed that CCK remarkably increased the firing frequency of action potentials (APs). The effects of CCK on neuronal excitability were mediated via activation of CCK-2 receptors and required the functions of G proteins and PLC. However, CCK-mediated facilitation of neuronal excitability was independent of inositol trisphosphate receptors and PKC. CCK facilitated neuronal excitability by activating a cationic channel to generate membrane depolarization. The effects of CCK were suppressed by the generic, nonselective cationic channel blockers, 2-aminoethyldiphenyl borate and flufenamic acid, but potentiated by gadolinium ion and lanthanum ion at 100 μM. Depletion of extracellular Ca(2+) also counteracted CCK-induced increases in AC firing frequency. Moreover, CCK-induced enhancement of neuronal excitability was inhibited significantly by intracellular application of the antibody to transient receptor potential channel 5 (TRPC5), suggesting the involvement of TRPC5 channels. Our results provide a cellular and molecular mechanism to help explain the functions of CCK in vivo.
authors.affiliation: Department of Pharmacology, Physiology and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58203, USA.
authors.forename: Shouping
authors.initials: S
authors.lastname: Wang
authors.forename: An-Ping
authors.initials: AP
authors.lastname: Zhang
authors.forename: Lalitha
authors.initials: L
authors.lastname: Kurada
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Matsui
authors.forename: Saobo
authors.initials: S
authors.lastname: Lei
mesh_terms: D000818:Animals; D000906:Antibodies / Q000633:toxicity; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000502:physiology*; D018728:Entorhinal Cortex / Q000502:physiology*; D051379:Mice; D018345:Mice, Knockout; D009474:Neurons / Q000276:immunology / Q000502:physiology*; D017966:Pyramidal Cells / Q000276:immunology / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D043887:Receptor, Cholecystokinin B / Q000172:deficiency / Q000235:genetics; D050052:TRPC Cation Channels / Q000276:immunology / Q000502:physiology*
chemical_list: D000906:Antibodies; D043887:Receptor, Cholecystokinin B; D050052:TRPC Cation Channels; C112021:Trpc5 protein, mouse; D002766:Cholecystokinin